Federal contract award
W81K0024P0080
318200 MERIDIAN H PYLORI SA - 100 TEST - TUBERCULOSIS AND HELICOBACTER PYLORI TESTING.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $117.5K |
| Current contract value | $161.4K |
| Potential contract value / ceiling | $249.2K |
| Start date | Oct 1, 2024 |
| Current end date | Sep 30, 2027 |
| Potential end date | Sep 30, 2029 |
| Latest award activity | Mar 20, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 20, 2026 | P00006 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE FY26 OPTION YEAR AND TO DECREASE PRICING ON SUBCLINS 0001AG, 1001AA,2001AA, 3001AA AND 4001AA. |
| Dec 8, 2025 | P00005 | $43.9K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE FY26 OPTION YEAR AND TO DECREASE PRICING ON SUBCLINS 0001AG, 1001AA,2001AA, 3001AA AND 4001AA. |
| Sep 5, 2025 | P00004 | $-519 | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE FY26 OPTION YEAR AND TO DECREASE PRICING ON SUBCLINS 0001AG, 1001AA,2001AA, 3001AA AND 4001AA. |
| Aug 14, 2025 | P00003 | $4.6K | THE PURPOSE OF THIS MODIFICATION IS TO ADD NEW CLINS AND DECREASE QUANTITIES. |
| Jul 30, 2025 | P00002 | $-6.0K | THE PURPOSE OF THIS MODIFICATION IS TO ADD NEW CLINS AND DECREASE QUANTITIES. |
| Feb 5, 2025 | P00001 | $75.5K | 318200 MERIDIAN H PYLORI SA - 100 TEST K - FY25 FUNDING MODIFICATION. |
| Apr 5, 2024 | 0 | $0 | 318200 MERIDIAN H PYLORI SA - 100 TEST - TUBERCULOSIS AND HELICOBACTER PYLORI TESTING. |
Estimated positioning window
Sep 30, 2028 – Mar 30, 2029
60/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 60/100. Available recorded signals: 55 points.
- Contract end 2029-09-30 (1064 days from calculation)
- +15 points
- 17 historical awards in this buyer and category group
- +15 points
- 7 recorded award transactions
- +10 points
- Latest award action: 2026-03-20
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.